Homebased Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) - Full Text View

Sponsors and Collaborators:	St. Olavs Hospital Community Health Network
Information provided by:	St. Olavs Hospital
ClinicalTrials.gov Identifier:	NCT00702078

Purpose

We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life.

The first main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.

Condition	Intervention
COPD	Behavioral: closer collaboration between hospital and primary healthcare system

MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title:	Randomised Clinical Study on the Effect of Homebased Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.

Further study details as provided by St. Olavs Hospital:

Primary Outcome Measures:

Number of hospitalizations ,quality of life [ Time Frame: 2011 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

lung function, use of medication, cost-effectiveness [ Time Frame: 2011 ] [ Designated as safety issue: No ]

Estimated Enrollment:	200
Study Start Date:	April 2008
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
C This arm is followed up according to todays best practice.	Behavioral: closer collaboration between hospital and primary healthcare system Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD

Eligibility

Ages Eligible for Study:	up to 95 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

clinical diagnosis of COPD (III-IV)
receive help from homecare nurse
not suffering from any other serious disease, with expected lifespan less than 6 months

Exclusion Criteria:

-

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00702078

Contacts

Contact: Anne Hildur Henriksen, MD, PhD	+47 73 86 85 79	anne.henriksen@stolav.no
Contact: Synnøve Sunde	+47 73 86 85 86	synnove.sunde@stolav.no

Locations

Norway
Dept. of Lung Diseases, St.Olavs Hospital	Recruiting
Trondheim, Norway, 7006
Contact: Anne Henriksen, MD, PhD +47 73 86 85 79 anne.henriksen@stolav.no
Contact: Synnøve Sunde +47 76 86 85 86 synnove.sunde@stolav.no
Principal Investigator: Rolf Walstad, Prof., DM

Sponsors and Collaborators

St. Olavs Hospital

Community Health Network

Investigators

Study Chair:

Anne Hildur Henriksen, MD,PhD

St.Olavs Hospital HF

More Information

Responsible Party:	St.Olavs Hospitlal, The University Hospital of Trondheim, Norway ( Henriksen, Anne Hildur, MD, PhD )
Study ID Numbers:	17417
Study First Received:	June 19, 2008
Last Updated:	June 19, 2008
ClinicalTrials.gov Identifier:	NCT00702078
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by St. Olavs Hospital:

COPD, homebased treatment, early intervention in COPD,

Study placed in the following topic categories:

Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on January 15, 2009